Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy: A case report and hypothesized mechanism of the therapy / 中西医结合学报
Journal of Integrative Medicine
; (12): 182-186, 2022.
Article
in En
| WPRIM
| ID: wpr-929218
Responsible library:
WPRO
ABSTRACT
Acupoint autohemotherapy at bilateral Zusanli (ST36) and Xuehai (SP10) was used to treat a 26-year-old female patient who had suffered from recalcitrant atopic eczema (AE) for five years. The treatment was applied at a frequency of once per week for the first month, followed by a three-month period of once every other week. At the end of treatment, the patient's AE symptoms were entirely resolved, and by the end of a six-month follow-up her immunoglobulin E level had returned to the normal range. Further, there was no relapse of AE symptoms during the six-month follow-up. Therefore, we hypothesized that after the repeated treatments the local inflammatory reaction induced by autologous blood injection triggered a local immune response, followed by a systemic immune response after the repeated treatment, finally leading to the anti-inflammation and immunomodulation effects. This case suggests that acupoint autohemotherapy could be used as an effective complementary treatment for recalcitrant AE, especially in cases where other treatments have failed. Further comparative studies are needed to corroborate the value and mechanisms of this therapy.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Acupuncture Points
/
Treatment Outcome
/
Dermatitis, Atopic
/
Inflammation
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Journal of Integrative Medicine
Year:
2022
Type:
Article